Published online 2 October 2006. doi:10.1083/jcb.200606058
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 175, Number 1, 111-120
BMP1 controls TGFß1 activation via cleavage of latent TGFß-binding protein
Gaoxiang Ge1 and
Daniel S. Greenspan1,2
1 Department of Pathology and Laboratory Medicine and 2 Department of Pharmacology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706
Correspondence to Daniel S. Greenspan: dsgreens{at}wisc.edu
Transforming growth factor ß1 (TGFß1), an important regulator of cell behavior, is secreted as a large latent complex (LLC) in which it is bound to its cleaved prodomain (latency-associated peptide [LAP]) and, via LAP, to latent TGFß-binding proteins (LTBPs). The latter target LLCs to the extracellular matrix (ECM). Bone morphogenetic protein 1 (BMP1)like metalloproteinases play key roles in ECM formation, by converting precursors into mature functional proteins, and in morphogenetic patterning, by cleaving the antagonist Chordin to activate BMP2/4. We provide in vitro and in vivo evidence that BMP1 cleaves LTBP1 at two specific sites, thus liberating LLC from ECM and resulting in consequent activation of TGFß1 via cleavage of LAP by nonBMP1-like proteinases. In mouse embryo fibroblasts, LAP cleavage is shown to be predominantly matrix metalloproteinase 2 dependent. TGFß1 is a potent inducer of ECM formation and of BMP1 expression. Thus, a role for BMP1-like proteinases in TGFß1 activation completes a novel fast-forward loop in vertebrate tissue remodeling.
Abbreviations used in this paper: AEBSF, 4-(2-aminoethyl)-benzenesulfonyl fluoride; BMP, bone morphogenetic protein; dpc, days post conception; GDF, growth and differentiation factor; LAP, latency-associated peptide; LLC, large latent complex; LTBP, latent TGFß-binding protein; MEF, mouse embryo fibroblast; MMP, matrix metalloproteinase; SLC, small latent complex; TAPI-2, TNF-
processing inhibitor 2; TIMP, tissue inhibitor of metalloproteinase; T-MLEC, transfected mink lung epithelial cell.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Cina, D., Patel, P., Bethune, J. C., Thoma, J., Rodriguez-Lecompte, J. C., Hoff, C. M., Liu, L., Margetts, P. J.
(2008). Peritoneal morphological and functional changes associated with platelet-derived growth factor B. Nephrol Dial Transplant
0: gfn498v1-gfn498
[Abstract]
[Full Text]
-
Bock, O., Hoftmann, J., Theophile, K., Hussein, K., Wiese, B., Schlue, J., Kreipe, H.
(2008). Bone Morphogenetic Proteins Are Overexpressed in the Bone Marrow of Primary Myelofibrosis and Are Apparently Induced by Fibrogenic Cytokines. Am. J. Pathol.
172: 951-960
[Abstract]
[Full Text]
-
Arrell, D. K., Niederlander, N. J., Faustino, R. S., Behfar, A., Terzic, A.
(2008). Cardioinductive Network Guiding Stem Cell Differentiation Revealed by Proteomic Cartography of Tumor Necrosis Factor {alpha}-Primed Endodermal Secretome. Stem Cells
26: 387-400
[Abstract]
[Full Text]
-
Wipff, P.-J., Rifkin, D. B., Meister, J.-J., Hinz, B.
(2007). Myofibroblast contraction activates latent TGF- 1 from the extracellular matrix. JCB
179: 1311-1323
[Abstract]
[Full Text]
-
Ge, G., Fernandez, C. A., Moses, M. A., Greenspan, D. S.
(2007). Bone morphogenetic protein 1 processes prolactin to a 17-kDa antiangiogenic factor. Proc. Natl. Acad. Sci. USA
104: 10010-10015
[Abstract]
[Full Text]
-
Blanc, G., Font, B., Eichenberger, D., Moreau, C., Ricard-Blum, S., Hulmes, D. J. S., Moali, C.
(2007). Insights into How CUB Domains Can Exert Specific Functions while Sharing a Common Fold: CONSERVED AND SPECIFIC FEATURES OF THE CUB1 DOMAIN CONTRIBUTE TO THE MOLECULAR BASIS OF PROCOLLAGEN C-PROTEINASE ENHANCER-1 ACTIVITY. J. Biol. Chem.
282: 16924-16933
[Abstract]
[Full Text]
-
Jasuja, R., Ge, G., Voss, N. G., Lyman-Gingerich, J., Branam, A. M., Pelegri, F. J., Greenspan, D. S.
(2007). Bone Morphogenetic Protein 1 Prodomain Specifically Binds and Regulates Signaling by Bone Morphogenetic Proteins 2 and 4. J. Biol. Chem.
282: 9053-9062
[Abstract]
[Full Text]
-
Chaudhry, S. S., Cain, S. A., Morgan, A., Dallas, S. L., Shuttleworth, C. A., Kielty, C. M.
(2007). Fibrillin-1 regulates the bioavailability of TGF{beta}1. JCB
176: 355-367
[Abstract]
[Full Text]